Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women

Osmanağaoğlu, Mehmet A.; Atasaral, T; Baltaci, Davut; Bozkaya, Hasan

doi:10.1080/13697130600997775

Cited by 20 publications

(7 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We did not measure physiological parameters directly but instead asked questions relating to menopause, hormone therapy, contraceptives, age, and health. There may be differences in the ways in which certain hormones (and combinations of hormones) [26,27] and particular classes of antidepressants may affect a woman's sexual response [28]. We did not differentiate between these drug classes because we did not have the statistical power for such a fine‐grained analysis.…”

Section: Discussionmentioning

confidence: 99%

Risk Factors for Female Sexual Dysfunction in the General Population: Exploring Factors Associated with Low Sexual Function and Sexual Distress

Hayes

Dennerstein

Bennett

et al. 2008

The Journal of Sexual Medicine

314

222

View full text Add to dashboard Cite

Introduction No previous population-based studies have used validated instruments to measure female sexual dysfunction (FSD) in Australian women across a broad age range. Aim To estimate prevalence and explore factors associated with the components of FSD. Main Outcome Measures Sexual Function Questionnaire measured low sexual function. Female Sexual Distress Scale measured sexual distress. Methods Multivariate analysis of postal survey data from a random sample of 356 women aged 20–70 years. Results Low desire was more likely to occur in women in relationships for 20–29 years (odds ratio 3.7, 95% confidence intervals 1.1–12.8) and less likely in women reporting greater satisfaction with their partner as a lover (0.3, 0.1–0.9) or who placed greater importance on sex (0.1, 0.03–0.3). Low genital arousal was more likely among women who were perimenopausal (4.4, 1.2–15.7), postmenopausal (5.3, 1.6–17.7), or depressed (2.5, 1.1–5.3), and was less likely in women taking hormone therapy (0.2, 0.04–0.7), more educated (0.5, 0.3–0.96), in their 30s (0.2, 0.1–0.7) or 40s (0.2, 0.1–0.7), or placed greater importance on sex (0.2, 0.05–0.5). Low orgasmic function was less likely in women who were in their 30s (0.3, 0.1–0.8) or who placed greater importance on sex (0.3, 0.1–0.7). Sexual distress was positively associated with depression (3.1, 1.2–7.8) and was inversely associated with better communication of sexual needs (0.2, 0.05–0.5). Results were adjusted for other covariates including age, psychological, socioeconomic, physiological, and relationship factors. Conclusions Relationship factors were more important to low desire than age or menopause, whereas physiological and psychological factors were more important to low genital arousal and low orgasmic function than relationship factors. Sexual distress was associated with both psychological and relationship factors.

show abstract

Section: Discussionmentioning

confidence: 99%

Risk Factors for Female Sexual Dysfunction in the General Population: Exploring Factors Associated with Low Sexual Function and Sexual Distress

Hayes

Dennerstein

Bennett

et al. 2008

The Journal of Sexual Medicine

314

222

View full text Add to dashboard Cite

show abstract

“…Women with urogenital discomfort are usually reluctant to be involved in sex. On the other hand HT is an effective option to improve vaginal lubrication and mood, and hence reduce painful intercourse [25,26]. Female education predicts a positive attitude toward sex and HT use [22,27].…”

Section: Discussionmentioning

confidence: 99%

Assessing predictors of sexual function in mid-aged sexually active women

Chedraui¹,

Pérez‐López

Mezones‐Holguín

et al. 2011

Maturitas

View full text Add to dashboard Cite

“…Tibolone is a synthetic steroid with estrogenic, progestagenic, and androgenic properties. Studies have suggested a positive effect on sexual function with use [145,146].…”

Section: Medical Treatment Of Fsdmentioning

confidence: 99%

Female sexual dysfunction

2007

View full text Add to dashboard Cite

Female sexual dysfunction is a common problem with detrimental effects on woman's quality of life. It also has an economical and societal impact. It is defined as disorders of sexual desire, arousal, orgasm, and sexual pain, which lead to personal distress. The etiology of sexual dysfunction is frequently multifactorial as it relates to general physical and mental well-being, quality of relationship, past sexual functioning, social class, education, employment, life stressors, personality factors, the presence of a sexual partner, and partner's age and health. It is very important to adopt the most efficient approach to gather information, and this may be achieved via standardized questionnaires or open-ended questions. Therapy should be tailored according to the patient's needs and may involve a multidisciplinary team approach including psychosexual counselor/sexologist/therapist and the physician. There is still more work needed to optimize the care of women with this problem. Priority should be given to international standardization and training of health care professionals.

show abstract

Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women

Abstract: Tibolone has more positive effects on the sexual dysfunction of postmenopausal women and may be an alternative to the E2/dienogest preparation in postmenopausal women with sexual dysfunction.

Cited by 20 publications

References 12 publications

Risk Factors for Female Sexual Dysfunction in the General Population: Exploring Factors Associated with Low Sexual Function and Sexual Distress

Risk Factors for Female Sexual Dysfunction in the General Population: Exploring Factors Associated with Low Sexual Function and Sexual Distress

Assessing predictors of sexual function in mid-aged sexually active women

Female sexual dysfunction

Contact Info

Product

Resources

About